Saso L - Search Results

1

Novel potential pharmacological applications of dimethyl fumarate-an overview and update.

Bresciani G, Manai F, Davinelli S, Tucci P, Saso L, Amadio M. Bresciani G, et al. Among authors: saso l. Front Pharmacol. 2023 Sep 7;14:1264842. doi: 10.3389/fphar.2023.1264842. eCollection 2023. Front Pharmacol. 2023. PMID: 37745068 Free PMC article. Review.

2

NRF2 signaling pathway and telomere length in aging and age-related diseases.

Medoro A, Saso L, Scapagnini G, Davinelli S. Medoro A, et al. Among authors: saso l. Mol Cell Biochem. 2023 Nov 2. doi: 10.1007/s11010-023-04878-x. Online ahead of print. Mol Cell Biochem. 2023. PMID: 37917279 Review.

3

Phenothiazines: Nrf2 activation and antioxidant effects.

Egbujor MC, Tucci P, Buttari B, Nwobodo DC, Marini P, Saso L. Egbujor MC, et al. Among authors: saso l. J Biochem Mol Toxicol. 2024 Mar;38(3):e23661. doi: 10.1002/jbt.23661. J Biochem Mol Toxicol. 2024. PMID: 38369721 Review.

4

An intricate rewiring of cancer metabolism via alternative splicing.

Temaj G, Chichiarelli S, Saha S, Telkoparan-Akillilar P, Nuhii N, Hadziselimovic R, Saso L. Temaj G, et al. Among authors: saso l. Biochem Pharmacol. 2023 Nov;217:115848. doi: 10.1016/j.bcp.2023.115848. Epub 2023 Oct 7. Biochem Pharmacol. 2023. PMID: 37813165 Review.

5

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment.

Rahban M, Joushi S, Bashiri H, Saso L, Sheibani V. Rahban M, et al. Among authors: saso l. Front Chem. 2024 Jan 8;11:1325214. doi: 10.3389/fchem.2023.1325214. eCollection 2023. Front Chem. 2024. PMID: 38264122 Free PMC article. Review.

6

Editorial: Targeting redox regulation and autophagy systems for cancer therapy.

Zhang J, Semlali A, Maycotte P, Saso L. Zhang J, et al. Among authors: saso l. Front Oncol. 2023 Jan 31;13:1146670. doi: 10.3389/fonc.2023.1146670. eCollection 2023. Front Oncol. 2023. PMID: 36798822 Free PMC article. No abstract available.

7

Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications.

Gallorini M, Carradori S, Panieri E, Sova M, Saso L. Gallorini M, et al. Among authors: saso l. Antioxid Redox Signal. 2024 Apr;40(10-12):636-662. doi: 10.1089/ars.2022.0213. Epub 2023 Sep 6. Antioxid Redox Signal. 2024. PMID: 37470218 Review.

8

Integrated approach to reducing polypharmacy in older people: exploring the role of oxidative stress and antioxidant potential therapy.

Rojas-Solé C, Pinilla-González V, Lillo-Moya J, González-Fernández T, Saso L, Rodrigo R. Rojas-Solé C, et al. Among authors: saso l. Redox Rep. 2024 Dec;29(1):2289740. doi: 10.1080/13510002.2023.2289740. Epub 2023 Dec 18. Redox Rep. 2024. PMID: 38108325 Free PMC article. Review.

9

Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters.

Nazari S, Mosaffa F, Poustforoosh A, Mortazavi M, Saso L, Firuzi O, Moosavi F. Nazari S, et al. Among authors: saso l. Toxicol Appl Pharmacol. 2024 Mar;484:116866. doi: 10.1016/j.taap.2024.116866. Epub 2024 Feb 15. Toxicol Appl Pharmacol. 2024. PMID: 38367674

10

Heteronemin promotes iron-dependent cell death in pancreatic cancer.

Kaftan G, Erdoğan MA, El-Shazly M, Lu MC, Shih SP, Lin HY, Saso L, Armagan G. Kaftan G, et al. Among authors: saso l. Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1865-1874. doi: 10.1007/s00210-023-02736-7. Epub 2023 Sep 29. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37773525

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

408 results

Search Page